Julia Mullenax
Gerontology · Little Rock, ARNPI 1376987719
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $864 of the $1,026 with a category attached, or 84.2%. It is spread thinly across 10 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $438 and has fallen 90.1% since, to $44 in 2025.
Across 14 payments — averaging $73.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$219
- Johnson & Johnson$185
- Karyopharm Therapeutics Inc.$134
- E.r. Squibb & Sons, L.L.C.$122
- Ipsen Biopharmaceuticals, Inc$112
- Genentech USA, Inc.$87
- plus $167 from 4 others
What the payments were for
- Food & beverage$86484%
- Education$16216%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 2 | $219 |
| Johnson & Johnson | 3 | $185 |
| Karyopharm Therapeutics Inc. | 1 | $134 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Ipsen Biopharmaceuticals, Inc | 1 | $112 |
| Genentech USA, Inc. | 1 | $87 |
| Lilly USA, LLC | 1 | $82 |
| Legend Biotech USA Inc. | 2 | $44 |
| Sanofi | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPOVIO$134
- ONUREG$122
- SOMATULINE DEPOT$112
- Reblozyl$102
How this compares
$1,026 in reported general payments places this provider in the 70th percentile of 89 gerontology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 11 | $407 |
| Potassium Chloride | 16 | $352 |
| Azithromycin | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Little Rock
- Rebekka AmickLittle Rock$6K
- Tamera DouglasLittle Rock$3K
- Samantha WattLittle Rock$3K
- Tiffany RecklingLittle Rock$2K
- Keely SparksLittle Rock$2K
- Robin BallLittle Rock$2K
- Lindsey ReynoldsLittle Rock$2K
- Valerie BeaversLittle Rock$2K
- Jennifer ThompsonLittle Rock$2K
- Franklin TondjoLittle Rock$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.